Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Wells Fargo launched coverage of AxoGen, Inc. (NASDAQ: AXGN) with an overweight rating and a $40.00 price target, implying roughly 13% upside from the current share price of $35.25. The bank highlighted AxoGen's exclusive focus on peripheral nerve repair and its lead off-the-shelf biologic graft product, Avance, as core advantages. The company is e…
Morgan Stanley raised Capgemini SA’s rating to equal-weight from underweight, pointing to a pronounced share price decline that has improved the stock’s risk-reward profile. The bank trimmed its price target to €117 from €142 due to a higher WACC and concerns about medium-term growth visibility amid potential AI-driven disruption. Capgemini posted …
TD Cowen has started coverage of GRAIL, Inc. (NASDAQ: GRAL) with a Hold rating and a $114 price target, reflecting an 11% potential upside from the stock's then-current price of $102.28. The firm's diligence — including calls with key opinion leaders, surveys, and literature reviews — supports a positive view of the multi-cancer early detection mar…
Hims & Hers Health announced it will acquire Australian digital health company Eucalyptus in a transaction valued at up to $1.15 billion. The purchase is designed to extend Hims & Hers' personalized care offerings into Australia and Japan and to strengthen access in the United Kingdom, Germany and Canada through regional partnerships. The deal incl…
Figma's stock jumped roughly 14% in premarket trading after the design-software firm provided a stronger-than-expected revenue forecast for 2026 and detailed plans to monetize embedded AI capabilities. Management said it will introduce AI credits and enforce limits for high-usage customers, while cautioning that AI investments, expanded operations …
UBS raised its recommendation on XL Axiata to Neutral from Sell while trimming its price target to IDR3,300 from IDR3,600. The bank cites stretched valuation metrics and the need for clearer merger synergy evidence before earnings momentum emerges, even as pricing trends and ARPU gains show improvement.
Canaccord Genuity has initiated coverage of Kiniksa Pharmaceuticals Inc. (KNSA) with a Buy rating and a $62 price target, noting the company’s commercial positioning around Arcalyst (rilonacept) for recurrent pericarditis. The stock is trading near its 52-week high after a strong one-year gain, while company revenues and physician adoption metrics …
Piper Sandler launched coverage of Perspective Therapeutics Inc (NYSE:CATX) with an overweight rating and a $16 price target, implying more than 200% upside from the stock's $5.03 level. The firm pointed to the company’s lead 212-based radiotherapy candidate, VMT-α-NET, and a distinctive safety profile as key positives. The company recently priced …
Deere & Co raised its full-year 2026 net income forecast after earlier cost reductions helped blunt the effect of weak equipment demand. The lift in guidance and signs of recovering demand in particular segments supported a premarket share increase. Management continues to work with dealers on inventory and had earlier cut factory production to mat…
Teck Resources reported adjusted fourth-quarter earnings above analyst expectations, driven by higher realized copper prices and increased production. The Canadian miner reiterated its 2026 copper output guidance while moving forward with a proposed all-stock merger with Anglo American that shareholders previously approved. Final regulatory clearan…
Barclays downgraded BASF to "underweight" and set a €40 price target, which implies about 21% downside from the Feb. 17 closing price of €50.62. The bank reduced its 2026 adjusted EBITDA forecast and highlighted a range of operational and structural risks including weak fourth-quarter results, potential European emissions cost increases, and challe…
Mizuho has begun coverage of Tempus AI Inc (NASDAQ: TEM) with an Outperform rating and a $100 price target, implying roughly 78% upside from recent levels. The broker highlights Tempus AI's strength in tissue-informed genomic profiling and potential growth in liquid biopsies, while third-party fair value analysis flags possible overvaluation at cur…
The Bundesbank says Germany's recovery will continue but with muted growth in the first quarter, and expects a stronger expansion from spring driven chiefly by fiscal stimulus. Headwinds for Q1 include weather-damaged construction activity and a likely cooling of private consumption, while industry faces export competitiveness challenges despite so…
President Donald Trump will speak in Rome, Georgia, focusing on measures he says will reduce costs for working Americans. The address comes as inflation readings show modest overall easing but persistent price pressures in food and housing, and as Republican control of Congress faces election-year uncertainty.
New drilling equipment arriving in Venezuela has raised hopes of a near-term uptick in crude production, but operators and service providers say even the simplest projects are complicated by damaged infrastructure, lost data, shortages of diluents and security and legal uncertainties. Early fixes using existing rigs, refurbishing wells and repairin…
A federal legal clash over California's longstanding authority to set its own vehicle-emissions rules has placed U.S. automakers in a precarious position. If congressional Republicans and the Trump administration prevail in revoking California's waiver, automakers could avoid stricter state mandates that favor electric vehicles (EVs). If California…
Hims & Hers’ announcement of a $49 compounded oral semaglutide pill intended to expand its weight-loss franchise provoked a swift response from regulators and Novo Nordisk, which called the product an illegal imitation and filed a patent suit. The retreat highlights manufacturing and regulatory hurdles for compounded GLP-1 products and raises quest…
Frontier Group Holdings is doubling down on budget-conscious flyers under new CEO James Dempsey, pursuing a return to a high-utilization, low-fare model even as many U.S. carriers emphasize premium passengers. Management disputes media rumors about a bankruptcy filing, attributes earlier booking gaps to a schedule overhaul, and says recent demand a…
Las Vegas recorded its largest annual decline in visitors outside the pandemic in 2025, with leisure travel and midweek demand weakening. The drop has translated into lower airport traffic, softer hotel pricing and contracting hours for service workers, even as conventions remain steadier. Industry data and executives point to high prices, politica…
Goldman Sachs has started covering Credo Technology Group Holding Ltd. (CRDO) with a Buy rating and a $165 price target, implying roughly 27% upside from the current share price. The initiation cites Credo's leadership in short-range datacenter wired connectivity - specifically Active Electrical Cables - strong recent revenue growth, and product ce…
Morgan Stanley's geospatial AlphaWise analysis links 1,272 announced AI-focused data center projects to roughly 80 GW of new power demand, projecting a probability-weighted increase of about +4.8 billion cubic feet per day (Bcf/d) in U.S. natural gas demand by 2030. The bank highlights concentrated growth in Appalachia and the PJM market and single…
UBS shifted Schroders Plc to a "neutral" stance from "buy," establishing a new 12-month price target of 590 pence after Nuveen submitted a recommended all-cash acquisition proposal valuing Schroders at £9.9 billion. The proposed package totals 612 pence per share - 590p in cash plus a 22p permitted dividend - and is backed by commitments representi…
Goldman Sachs strategists report that recent equity gains have broadened beyond a handful of technology giants, boosting mutual fund performance. Improved market breadth and wider dispersion across the S&P 500 have coincided with a high share of large-cap active mutual funds outperforming benchmarks year-to-date, driven in part by weakness among me…
Bayer responded to a U.S. presidential order invoking the Defense Production Act to safeguard domestic glyphosate supply by saying the move reflects U.S. farmers' need for the herbicide and will not create shortages outside the United States. The company has warned previously that continuing litigation could force a halt to U.S. production unless r…
Carvana's stock fell sharply in premarket trading after the online-only used-vehicle retailer reported a fourth-quarter profit that missed Wall Street expectations. Management attributed the shortfall to larger-than-expected inspection, repair and detailing costs across multiple production sites and to higher retail depreciation rates that weighed …
